Apomorphine Injection

Generic name: Pronounced as (a poe mor' feen)
Brand names
  • Apokyn®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2022

Apomorphine injection is used to treat ''off'' episodes (times of difficulty moving, walking, and speaking that may happen as medication wears off or at random) in people with advanced Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) who are taking other medications for their condition. Apomorphine injection is in a class of medications called dopamine agonists. It works by acting in place of dopamine, a natural substance produced in the brain that is needed to control movement.

Apomorphine comes as a solution to inject subcutaneously (just under the skin). Apomorphine is usually injected when needed, according to your doctor's directions. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use apomorphine injection exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.

Do not use a second dose of apomorphine injection for treatment of the same "off" episode. Wait at least 2 hours between doses.

Your doctor will give you another medication called trimethobenzamide (Tigan) to take when you begin to use apomorphine injection. This medication will help decrease your chance of developing nausea and vomiting while you are using apomorphine injection, especially during the beginning of treatment. Your doctor will probably tell you to begin taking trimethobenzamide a few days before you begin to use apomorphine injection, and to continue taking it for up to 2 months. You should know that taking trimethobenzamide along with apomorphine injection may increase your risk of drowsiness, dizziness, and falls. However, do not stop taking trimethobenzamide without first talking to your doctor.

Your doctor will probably start you on a low dose of apomorphine injection and gradually increase your dose, not more than once every few days. Ask your doctor what to do if you do not use apomorphine injection for longer than 1 week. Your doctor will probably tell you to restart this medication using a low dose and gradually increase your dose.

Apomorphine solution comes in a glass cartridge to use with an injector pen. Some needles are provided with your pen and additional needles are sold separately. Ask your doctor or pharmacist if you have questions about the type of needle you need. Always use a new, sterile needle for each injection. Never reuse needles, and never let a needle touch any surface except the place where you will inject the medicine. Never store or carry the injector pen with a needle attached. Discard used needles in a puncture-resistant container kept out of reach of children. Talk to your doctor or pharmacist about how to discard the puncture-resistant container.

You will receive your first dose of apomorphine injection in a medical office where your doctor can closely monitor your condition. After that, your doctor may tell you that you can inject apomorphine yourself or have a friend or relative perform the injections. Before you use apomorphine injection yourself the first time, read the written instructions that come with it. Ask your doctor or pharmacist to show you or the person who will be injecting the medication how to inject it.

Be sure you know what numbers on the injector pen show your dose. Your doctor may have told you how many milligrams you need to use, but the pen is marked with milliliters. Ask your doctor or pharmacist if you are not sure how to find your dose on the injector pen.

The apomorphine injector pen is only for use by one person. Do not share your pen with anyone.

Be careful not to get apomorphine injection on your skin or in your eyes. If apomorphine injection does get on your skin or in your eyes, immediately wash your skin or flush your eyes with cold water.

You can inject apomorphine in your stomach area, upper arm, or upper leg. Do not inject into a vein or in an area where the skin is sore, red, bruised, scarred, infected, or abnormal in any way. Use a different spot for each injection, choosing from among the spots you have been told to use. Keep a record of the date and spot of each injection. Do not use the same spot two times in a row.

Always look at your apomorphine solution before you inject it. It should be clear, colorless, and free of particles. Do not use apomorphine if it is cloudy, green, contains particles, or if the expiration date on the carton has passed.

Keep a record of how much apomorphine injection you use each time you receive an injection so that you will know when to replace the medication cartridge.

You may clean your apomorphine injector pen with a damp cloth as needed. Never use strong disinfectants or wash your pen under running water.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using apomorphine injection,

  • tell your doctor and pharmacist if you are allergic to apomorphine, any other medications, sulfites, or any other ingredients in apomorphine injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are taking alosetron (Lotronex), dolasetron (Anzemet), granisetron (Sancuso), ondansetron (Zofran), or palonosetron (Aloxi). Your doctor will probably tell you not to use apomorphine injection if you are taking one of these medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: allergy, cough and cold medications; amiodarone (Nexterone, Pacerone); antidepressants; antihistamines; chlorpromazine; disopyramide (Norpace); dofetilide (Tikosyn); erythromycin (E.E.S.); haloperidol (Haldol); medications to treat mental illness, upset stomach, heart disease, high blood pressure, pain, or seizures; metoclopramide (Reglan); moxifloxacin (Avelox); muscle relaxants; other medications for Parkinson's disease; pimozide (Orap); procainamide; prochlorperazine (Compro); promethazine; quinidine (in Nuedexta); sedatives; sildenafil (Viagra, Revatio); sleeping pills; sotalol (Betapace); tadalafil (Cialis); tranquilizers; vardenafil (Levitra); or nitrates such as isosorbide dinitrate (Isordil, in Bidil), isosorbide mononitrate (Monoket), or nitroglycerin (Nitro-Dur, Nitrostat, others). Nitrates come as tablets, sublingual (under the tongue) tablets, sprays, patches, pastes, and ointments. Ask your doctor if you are not sure if any of your medications contain nitrates. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with apomorphine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • you should know that if you take nitroglycerin under your tongue while using apomorphine injection, your blood pressure may decrease and cause dizziness. After taking nitroglycerin tablets under your tongue, you should lie down for at least 45 minutes and avoid standing during this time.

  • tell your doctor if you drink alcohol or if you have or have ever had asthma; dizziness; fainting spells; a slow or irregular heartbeat; low blood pressure; low levels of potassium or magnesium in the blood; mental illness; a sleep disorder; a stroke, mini-stroke, or other brain problems; sudden uncontrolled movements and falls; or heart, kidney, or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while using apomorphine injection, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are using apomorphine injection.

  • you should know that apomorphine injection may make you drowsy. Do not drive a car, operate machinery, or do anything that might put you at risk of getting hurt until you know how this medication affects you.

  • you should know that you may suddenly fall asleep during your regular daily activities while you are using apomorphine injection. You may not feel drowsy before you fall asleep. If you suddenly fall asleep while you are doing an everyday activity such as eating, talking, or watching television, call your doctor. Do not drive a car or operate machinery until you talk to your doctor.

  • you should not drink alcohol while you are using apomorphine injection. Alcohol can make the side effects from apomorphine injection worse.

  • you should know that some people who took medications such as apomorphine injection developed gambling problems or other intense urges or behaviors that were compulsive or unusual for them, such as increased sexual urges or behaviors. There is not enough information to tell whether the people developed these problems because they took the medication or for other reasons. Call your doctor if you have an urge to gamble that is difficult to control, you have intense urges, or you are unable to control your behavior. Tell your family members about this risk so that they can call the doctor even if you do not realize that your gambling or any other intense urges or unusual behaviors have become a problem.

  • you should know that apomorphine injection may cause dizziness, lightheadedness, nausea, sweating, and fainting when you get up too quickly from a lying or sitting position. This is more common when you first start using apomorphine injection or following an increase in dose. To avoid this problem, get out of bed or get up from a seated position slowly, resting your feet on the floor for a few minutes before standing up.

Unless your doctor tells you otherwise, continue your normal diet.

This medication is usually used as needed.

  • Apomorphine injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • constipation

    • diarrhea

    • headache

    • yawning

    • runny nose

    • weakness

    • arm, leg, or back pain

    • pain or difficulty in urination

    • soreness, redness, pain, bruising, swelling, or itching in the place where you injected apomorphine

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

    • rash; hives; itching; swelling of the face, throat, tongue, lips, or eyes; difficulty breathing and swallowing; shortness of breath;cough; or hoarseness

    • fainting

    • fast or pounding heartbeat

    • chest pain

    • swelling of the hands, feet, ankles, or lower legs

    • bruising

    • sudden uncontrollable movements

    • falling down

    • hallucinations (seeing things or hearing voices that do not exist), aggressive behavior, agitation, feeling like people are against you, or disorganized thoughts

    • depression

    • fever

    • confusion

    • painful erection that does not go away

  • Some laboratory animals that were given apomorphine injection developed eye disease. It is not known if apomorphine injection increases the risk of eye disease in humans. Talk to your doctor about the risks of using this medication.

  • Apomorphine may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the cartridge it came in and out of reach of children. Store it in the carrying case at room temperature and away from light, excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • nausea

  • fainting

  • dizziness

  • blurred vision

  • slow heartbeat

  • abnormal behavior

  • hallucinations

  • sudden uncontrollable movements

Keep all appointments with your doctor.

Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Moxifloxacin.
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Apomorphine.
Montelukast Montelukast The metabolism of Apomorphine can be decreased when combined with Montelukast.
Delavirdine Delavirdine The metabolism of Apomorphine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Apomorphine can be increased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Apomorphine.
Dolasetron Dolasetron The risk or severity of hypotension can be increased when Apomorphine is combined with Dolasetron.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Anagrelide.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Apomorphine.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Cilostazol.
Clopidogrel Clopidogrel The metabolism of Apomorphine can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Apomorphine is combined with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Erythromycin.
Fenofibrate Fenofibrate The metabolism of Apomorphine can be decreased when combined with Fenofibrate.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Apomorphine is combined with Guanfacine.
Methylergonovine Methylergonovine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Methylergometrine.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Apomorphine is combined with Naratriptan.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Apomorphine.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Acebutolol.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Apomorphine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Apomorphine.
Rizatriptan Rizatriptan The risk or severity of adverse effects can be increased when Apomorphine is combined with Rizatriptan.
Sumatriptan Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Apomorphine.
Tacrolimus Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Apomorphine.
Tizanidine Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Apomorphine.
Triamcinolone Triamcinolone The metabolism of Apomorphine can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Apomorphine.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Apomorphine.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Apomorphine.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Apomorphine.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Apomorphine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Apomorphine.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Apomorphine.
Zidovudine Injection Zidovudine Injection The metabolism of Apomorphine can be decreased when combined with Zidovudine.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Apomorphine.
Cyclosporine Cyclosporine The metabolism of Apomorphine can be decreased when combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Apomorphine.
Granisetron Granisetron The risk or severity of hypotension can be increased when Apomorphine is combined with Granisetron.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Apomorphine.
Olanzapine Olanzapine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Olanzapine.
Alosetron Alosetron The risk or severity of hypotension can be increased when Apomorphine is combined with Alosetron.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Dofetilide.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Apomorphine.
Eprosartan Eprosartan The risk or severity of adverse effects can be increased when Apomorphine is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Hydroxychloroquine.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Apomorphine is combined with Oxcarbazepine.
Telmisartan Telmisartan The risk or severity of adverse effects can be increased when Apomorphine is combined with Telmisartan.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Apomorphine is combined with Zaleplon.
Anakinra Anakinra The metabolism of Apomorphine can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Desloratadine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Apomorphine.
Trimipramine Trimipramine The risk or severity of adverse effects can be increased when Apomorphine is combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Apomorphine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Apomorphine can be increased when combined with Modafinil.
Perindopril Perindopril The risk or severity of adverse effects can be increased when Apomorphine is combined with Perindopril.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Apomorphine.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Apomorphine.
Eplerenone Eplerenone The risk or severity of adverse effects can be increased when Apomorphine is combined with Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Escitalopram.
Olmesartan Olmesartan The risk or severity of adverse effects can be increased when Apomorphine is combined with Olmesartan.
Zonisamide Zonisamide The risk or severity of adverse effects can be increased when Apomorphine is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Apomorphine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of adverse effects can be decreased when Apomorphine is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Apomorphine.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Apomorphine.
Atazanavir Atazanavir The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Atazanavir.
Almotriptan Almotriptan The risk or severity of adverse effects can be increased when Apomorphine is combined with Almotriptan.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Apomorphine.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Apomorphine.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Apomorphine.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vardenafil.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Apomorphine.
Aprepitant Aprepitant The metabolism of Apomorphine can be decreased when combined with Aprepitant.
Memantine Memantine The metabolism of Apomorphine can be decreased when combined with Memantine.
Tegaserod Tegaserod The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Tegaserod.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Apomorphine.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Apomorphine is combined with Frovatriptan.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Apomorphine can be decreased when combined with Progesterone.
Infliximab Injection Infliximab Injection The metabolism of Apomorphine can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Apomorphine.
Rifaximin Rifaximin The metabolism of Apomorphine can be increased when combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Apomorphine is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Apomorphine.
Trospium Trospium Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Apomorphine may increase the hypotensive activities of Bosentan.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Apomorphine.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Apomorphine is combined with Eszopiclone.
Solifenacin Solifenacin Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Apomorphine.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Apomorphine.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Apomorphine.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Apomorphine is combined with Isocarboxazid.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Apomorphine is combined with Ramelteon.
Darifenacin Darifenacin Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Apomorphine is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Apomorphine can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The metabolism of Apomorphine can be decreased when combined with Deferasirox.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Apomorphine is combined with Felbamate.
Ranolazine Ranolazine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Apomorphine can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Apomorphine is combined with Rasagiline.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Imatinib.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Apomorphine.
Gefitinib Gefitinib The metabolism of Apomorphine can be decreased when combined with Gefitinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Salbutamol.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Apomorphine.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Apomorphine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Posaconazole.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Primaquine.
Aliskiren Aliskiren The risk or severity of adverse effects can be increased when Apomorphine is combined with Aliskiren.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Apomorphine can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Apomorphine.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Apomorphine is combined with Levocetirizine.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Apomorphine.
Mexiletine Mexiletine The metabolism of Apomorphine can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Apomorphine can be increased when combined with Armodafinil.
Temsirolimus Temsirolimus The metabolism of Apomorphine can be decreased when combined with Temsirolimus.
Nilotinib Nilotinib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Apomorphine can be decreased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Apomorphine can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Apomorphine can be decreased when combined with Chloramphenicol.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Apomorphine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apomorphine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine The risk or severity of adverse effects can be increased when Apomorphine is combined with Desvenlafaxine.
Nebivolol Nebivolol The risk or severity of adverse effects can be increased when Apomorphine is combined with Nebivolol.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Apomorphine.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Apomorphine can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Apomorphine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Apomorphine.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Apomorphine.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Apomorphine.
Naltrexone Injection Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Apomorphine.
Eltrombopag Eltrombopag The metabolism of Apomorphine can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The risk or severity of adverse effects can be increased when Apomorphine is combined with Milnacipran.
Fesoterodine Fesoterodine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Degarelix.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Betaxolol.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Iloperidone.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Apomorphine.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Apomorphine is combined with Lacosamide.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Apomorphine.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Apomorphine.
Palonosetron Injection Palonosetron Injection The risk or severity of hypotension can be increased when Palonosetron is combined with Apomorphine.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Apomorphine.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Golimumab Injection Golimumab Injection The metabolism of Apomorphine can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Apomorphine.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Apomorphine is combined with Vigabatrin.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Apomorphine.
Levonorgestrel Levonorgestrel The metabolism of Apomorphine can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Apomorphine is combined with Oxymorphone.
Tocilizumab Injection Tocilizumab Injection The metabolism of Apomorphine can be increased when combined with Tocilizumab.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Eribulin.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Apomorphine.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Apomorphine.
Lurasidone Lurasidone The therapeutic efficacy of Apomorphine can be decreased when used in combination with Lurasidone.
Vilazodone Vilazodone The risk or severity of adverse effects can be increased when Apomorphine is combined with Vilazodone.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apomorphine.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Terbutaline.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Apomorphine is combined with Azilsartan medoxomil.
Rilpivirine Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Apomorphine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Apomorphine can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Apomorphine can be decreased when combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Triptorelin.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Apomorphine.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vandetanib.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Apomorphine.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Vemurafenib.
Vismodegib Vismodegib The metabolism of Apomorphine can be decreased when combined with Vismodegib.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Apomorphine.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Apomorphine.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Apomorphine.
Cabergoline Cabergoline The risk or severity of adverse effects can be decreased when Cabergoline is combined with Apomorphine.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Apomorphine.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Apomorphine is combined with Tiagabine.
Iloprost Iloprost The risk or severity of adverse effects can be increased when Apomorphine is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Apomorphine can be decreased when combined with Enzalutamide.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Apomorphine can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Apomorphine can be decreased when combined with Bosutinib.
Teriflunomide Teriflunomide The metabolism of Apomorphine can be decreased when combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Apomorphine can be decreased when combined with Cabozantinib.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Bedaquiline.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Apomorphine.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Apomorphine is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Apomorphine.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Apomorphine.
Canagliflozin Canagliflozin The risk or severity of adverse effects can be increased when Apomorphine is combined with Canagliflozin.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Methazolamide is combined with Apomorphine.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Apomorphine.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Apomorphine.
Trametinib Trametinib The metabolism of Apomorphine can be decreased when combined with Trametinib.
Levomilnacipran Levomilnacipran The risk or severity of adverse effects can be increased when Apomorphine is combined with Levomilnacipran.
Vortioxetine Vortioxetine The risk or severity of hypotension can be increased when Apomorphine is combined with Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Apomorphine.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Apomorphine.
Ketorolac Injection Ketorolac Injection The metabolism of Apomorphine can be decreased when combined with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Obinutuzumab.
Dapagliflozin Dapagliflozin The risk or severity of adverse effects can be increased when Apomorphine is combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Apomorphine can be increased when combined with Apremilast.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Apomorphine can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Apomorphine is combined with Eslicarbazepine.
Testosterone Injection Testosterone Injection The metabolism of Apomorphine can be decreased when combined with Testosterone.
Empagliflozin Empagliflozin The risk or severity of adverse effects can be increased when Apomorphine is combined with Empagliflozin.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Suvorexant Suvorexant Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Apomorphine.
Methamphetamine Methamphetamine The risk or severity of adverse effects can be increased when Apomorphine is combined with Metamfetamine.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Apomorphine is combined with Tasimelteon.
Riociguat Riociguat The metabolism of Riociguat can be decreased when combined with Apomorphine.
Secukinumab Injection Secukinumab Injection The metabolism of Apomorphine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Apomorphine may increase the hypotensive activities of Risperidone.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ivabradine.
Amiloride Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Apomorphine.
Macitentan Macitentan Apomorphine may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Apomorphine is combined with Flibanserin.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Apomorphine.
Brexpiprazole Brexpiprazole The risk or severity of adverse effects can be decreased when Apomorphine is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ziprasidone.
Cariprazine Cariprazine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Cariprazine.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Eluxadoline.
Rifapentine Rifapentine The metabolism of Apomorphine can be increased when combined with Rifapentine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Apomorphine.
Dexamethasone Injection Dexamethasone Injection The metabolism of Apomorphine can be increased when combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Brivaracetam.
Cobicistat Cobicistat The metabolism of Apomorphine can be decreased when combined with Cobicistat.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Apomorphine.
Pimavanserin Pimavanserin The therapeutic efficacy of Apomorphine can be decreased when used in combination with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection The risk or severity of adverse effects can be increased when Furosemide is combined with Apomorphine.
Rucaparib Rucaparib The metabolism of Apomorphine can be decreased when combined with Rucaparib.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Apomorphine.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of adverse effects can be increased when Apomorphine is combined with Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Apomorphine.
Deflazacort Deflazacort The metabolism of Apomorphine can be increased when combined with Deflazacort.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Apomorphine is combined with Safinamide.
Midostaurin Midostaurin The metabolism of Apomorphine can be increased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Apomorphine can be decreased when combined with Enasidenib.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Apomorphine.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Delafloxacin.
Acalabrutinib Acalabrutinib The metabolism of Apomorphine can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Apomorphine can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Tetrabenazine.
Buprenorphine Injection Buprenorphine Injection Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The metabolism of Apalutamide can be decreased when combined with Apomorphine.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Apomorphine.
Avatrombopag Avatrombopag The metabolism of Apomorphine can be increased when combined with Avatrombopag.
Lofexidine Lofexidine The therapeutic efficacy of Apomorphine can be increased when used in combination with Lofexidine.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Encorafenib.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Apomorphine.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Apomorphine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Apomorphine.
Stiripentol Stiripentol The risk or severity of adverse effects can be increased when Apomorphine is combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Apomorphine can be decreased when used in combination with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Apomorphine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Apomorphine.
Rifamycin Rifamycin The metabolism of Apomorphine can be decreased when combined with Rifamycin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Apomorphine can be increased when combined with Emapalumab.
Alpelisib Alpelisib The metabolism of Apomorphine can be decreased when combined with Alpelisib.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Brexanolone.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Apomorphine is combined with Solriamfetol.
Triclabendazole Triclabendazole The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Apomorphine.
Pitolisant Pitolisant Apomorphine may increase the QTc-prolonging activities of Pitolisant.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Apomorphine.
Phenytoin Injection Phenytoin Injection The metabolism of Apomorphine can be decreased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Apomorphine.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Apomorphine.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Apomorphine.
Lumateperone Lumateperone The therapeutic efficacy of Apomorphine can be decreased when used in combination with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Lasmiditan.
Cenobamate Cenobamate The serum concentration of Apomorphine can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The metabolism of Ozanimod can be decreased when combined with Apomorphine.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Apomorphine.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Apomorphine.
Selpercatinib Selpercatinib The serum concentration of Apomorphine can be increased when it is combined with Selpercatinib.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Apomorphine.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Apomorphine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Fostemsavir.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Apomorphine.
Pralsetinib Pralsetinib The metabolism of Apomorphine can be decreased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Apomorphine can be decreased when combined with Opicapone.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Relugolix.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Apomorphine is combined with Viloxazine.
Theophylline Theophylline The metabolism of Apomorphine can be decreased when combined with Theophylline.
Mefenamic Acid Mefenamic Acid The metabolism of Apomorphine can be decreased when combined with Mefenamic acid.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Apomorphine.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Apomorphine.
Phenobarbital Phenobarbital The metabolism of Apomorphine can be increased when combined with Phenobarbital.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Apomorphine.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Apomorphine is combined with Levorphanol.
Primidone Primidone Primidone may increase the hypotensive activities of Apomorphine.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Apomorphine is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Apomorphine is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Chlorpromazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Apomorphine is combined with Diazepam.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Apomorphine is combined with Oxazepam.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Apomorphine.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Apomorphine.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Apomorphine.
Phenoxybenzamine Phenoxybenzamine The risk or severity of adverse effects can be increased when Apomorphine is combined with Phenoxybenzamine.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Amantadine.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Apomorphine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Apomorphine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Apomorphine.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be decreased when Apomorphine is combined with Bromocriptine.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Apomorphine is combined with Tranylcypromine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Apomorphine is combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Apomorphine is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be decreased when Apomorphine is combined with Ergoloid mesylate.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Prochlorperazine Prochlorperazine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Prochlorperazine.
Thioridazine Thioridazine The therapeutic efficacy of Thioridazine can be decreased when used in combination with Apomorphine.
Trifluoperazine Trifluoperazine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Trifluoperazine.
Dapsone Dapsone The metabolism of Apomorphine can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The metabolism of Apomorphine can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Apomorphine.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Apomorphine.
Oxybutynin Oxybutynin Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Apomorphine is combined with Maprotiline.
Ibuprofen Ibuprofen The metabolism of Ibuprofen can be decreased when combined with Apomorphine.
Trihexyphenidyl Trihexyphenidyl Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Perphenazine.
Fluphenazine Fluphenazine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Fluphenazine.
Phentermine Phentermine The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Apomorphine.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Apomorphine.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Apomorphine.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be increased when combined with Apomorphine.
Doxorubicin Doxorubicin The metabolism of Apomorphine can be decreased when combined with Doxorubicin.
Carbamazepine Carbamazepine The metabolism of Apomorphine can be decreased when combined with Carbamazepine.
Molindone Molindone The therapeutic efficacy of Apomorphine can be decreased when used in combination with Molindone.
Methyldopa Methyldopa The risk or severity of adverse effects can be increased when Apomorphine is combined with Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Apomorphine.
Prazosin Prazosin The risk or severity of adverse effects can be increased when Apomorphine is combined with Prazosin.
Hydralazine Hydralazine The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Apomorphine can be decreased when combined with Cimetidine.
Warfarin Warfarin The metabolism of Warfarin can be decreased when combined with Apomorphine.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Apomorphine is combined with Clonazepam.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Loperamide.
Promethazine Promethazine The risk or severity of adverse effects can be increased when Apomorphine is combined with Promethazine.
Daunorubicin Daunorubicin The metabolism of Apomorphine can be increased when combined with Daunorubicin.
Griseofulvin Griseofulvin The metabolism of Apomorphine can be increased when combined with Griseofulvin.
Digoxin Digoxin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Apomorphine.
Loxapine Loxapine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Loxapine.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Chloroquine.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Apomorphine.
Triamterene Triamterene The risk or severity of adverse effects can be increased when Triamterene is combined with Apomorphine.
Sulfinpyrazone Sulfinpyrazone The metabolism of Apomorphine can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of adverse effects can be increased when Apomorphine is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Apomorphine is combined with Chlorthalidone.
Metolazone Metolazone The risk or severity of adverse effects can be increased when Apomorphine is combined with Metolazone.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Apomorphine.
Secobarbital Secobarbital The metabolism of Apomorphine can be increased when combined with Secobarbital.
Desipramine Desipramine The risk or severity of adverse effects can be increased when Apomorphine is combined with Desipramine.
Amitriptyline Amitriptyline The risk or severity of adverse effects can be increased when Amitriptyline is combined with Apomorphine.
Imipramine Imipramine The risk or severity of adverse effects can be increased when Imipramine is combined with Apomorphine.
Probenecid Probenecid The metabolism of Apomorphine can be increased when combined with Probenecid.
Quinidine Quinidine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quinidine.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Procainamide.
Isoniazid Isoniazid The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Isoniazid.
Rifampin Rifampin The metabolism of Apomorphine can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Apomorphine can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Apomorphine.
Levothyroxine Levothyroxine The metabolism of Apomorphine can be decreased when combined with Levothyroxine.
Methimazole Methimazole The metabolism of Apomorphine can be decreased when combined with Methimazole.
Tolbutamide Tolbutamide The metabolism of Apomorphine can be decreased when combined with Tolbutamide.
Dextromethorphan Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Apomorphine.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Apomorphine is combined with Cyclobenzaprine.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Apomorphine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.
Cyproheptadine Cyproheptadine The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Apomorphine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Apomorphine is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Apomorphine.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Apomorphine is combined with Meclizine.
Methyclothiazide Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Apomorphine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Apomorphine is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Apomorphine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Apomorphine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Apomorphine.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Propranolol.
Minoxidil Minoxidil The risk or severity of adverse effects can be increased when Apomorphine is combined with Minoxidil.
Pseudoephedrine Pseudoephedrine The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The risk or severity of adverse effects can be increased when Nortriptyline is combined with Apomorphine.
Spironolactone Spironolactone The metabolism of Apomorphine can be decreased when combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Apomorphine.
Nadolol Nadolol The risk or severity of adverse effects can be increased when Apomorphine is combined with Nadolol.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Apomorphine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Nalbuphine.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Apomorphine.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Apomorphine.
Flavoxate Flavoxate Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Apomorphine.
Colchicine Colchicine The metabolism of Apomorphine can be decreased when combined with Colchicine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Apomorphine is combined with Acetazolamide.
Ketoconazole Ketoconazole The metabolism of Ketoconazole can be decreased when combined with Apomorphine.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Apomorphine is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The metabolism of Apomorphine can be decreased when combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Apomorphine can be decreased when combined with Vincristine.
Captopril Captopril The risk or severity of adverse effects can be increased when Apomorphine is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of adverse effects can be increased when Apomorphine is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of adverse effects can be increased when Apomorphine is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Apomorphine is combined with Etacrynic acid.
Metoprolol Metoprolol The risk or severity of adverse effects can be increased when Apomorphine is combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Apomorphine.
Thiothixene Thiothixene The therapeutic efficacy of Apomorphine can be decreased when used in combination with Thiothixene.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Apomorphine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Apomorphine.
Triazolam Triazolam The risk or severity of adverse effects can be increased when Apomorphine is combined with Triazolam.
Dicyclomine Dicyclomine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The metabolism of Apomorphine can be decreased when combined with Trimethoprim.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Timolol.
Verapamil Verapamil The metabolism of Apomorphine can be decreased when combined with Verapamil.
Atenolol Atenolol The risk or severity of adverse effects can be increased when Apomorphine is combined with Atenolol.
Pindolol Pindolol The risk or severity of adverse effects can be increased when Apomorphine is combined with Pindolol.
Cisplatin Injection Cisplatin Injection The metabolism of Apomorphine can be decreased when combined with Cisplatin.
Piroxicam Piroxicam The metabolism of Apomorphine can be decreased when combined with Piroxicam.
Bumetanide Bumetanide The risk or severity of adverse effects can be increased when Apomorphine is combined with Bumetanide.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Apomorphine.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Apomorphine.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Indapamide.
Pentoxifylline Pentoxifylline The risk or severity of hypotension can be increased when Pentoxifylline is combined with Apomorphine.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Pentamidine.
Labetalol Labetalol The risk or severity of adverse effects can be increased when Apomorphine is combined with Labetalol.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Apomorphine can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz Apomorphine may increase the hypotensive activities of Guanabenz.
Ketoprofen Ketoprofen The metabolism of Apomorphine can be decreased when combined with Ketoprofen.
Pimozide Pimozide The therapeutic efficacy of Pimozide can be decreased when used in combination with Apomorphine.
Enalapril Enalapril The risk or severity of adverse effects can be increased when Apomorphine is combined with Enalapril.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Apomorphine.
Buspirone Buspirone The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Apomorphine.
Lovastatin Lovastatin The metabolism of Apomorphine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Apomorphine can be decreased when combined with Diclofenac.
Fluoxetine Fluoxetine The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Nimodipine.
Clozapine Clozapine The therapeutic efficacy of Apomorphine can be decreased when used in combination with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Apomorphine is combined with Estazolam.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ofloxacin.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be decreased when combined with Apomorphine.
Benazepril Benazepril The risk or severity of adverse effects can be increased when Apomorphine is combined with Benazepril.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Apomorphine.
Fosinopril Fosinopril The risk or severity of adverse effects can be increased when Apomorphine is combined with Fosinopril.
Quinapril Quinapril The risk or severity of adverse effects can be increased when Apomorphine is combined with Quinapril.
Ramipril Ramipril The risk or severity of adverse effects can be increased when Apomorphine is combined with Ramipril.
Simvastatin Simvastatin The metabolism of Apomorphine can be decreased when combined with Simvastatin.
Amlodipine Amlodipine The risk or severity of adverse effects can be increased when Apomorphine is combined with Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Apomorphine can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Itraconazole can be decreased when combined with Apomorphine.
Lisinopril Lisinopril The risk or severity of adverse effects can be increased when Apomorphine is combined with Lisinopril.
Rifabutin Rifabutin The metabolism of Apomorphine can be increased when combined with Rifabutin.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Sotalol.
Bisoprolol Bisoprolol The risk or severity of adverse effects can be increased when Apomorphine is combined with Bisoprolol.
Zolpidem Zolpidem Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The risk or severity of adverse effects can be increased when Apomorphine is combined with Doxazosin.
Terazosin Terazosin The risk or severity of adverse effects can be increased when Apomorphine is combined with Terazosin.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Isradipine.
Omeprazole Omeprazole The metabolism of Apomorphine can be decreased when combined with Omeprazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Cisapride.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Apomorphine is combined with Gabapentin.
Fluvastatin Fluvastatin The metabolism of Apomorphine can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Apomorphine.
Fluvoxamine Fluvoxamine The risk or severity of adverse effects can be increased when Apomorphine is combined with Fluvoxamine.
Nefazodone Nefazodone The risk or severity of adverse effects can be increased when Apomorphine is combined with Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Apomorphine.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Losartan.
Tramadol Tramadol The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Apomorphine.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Apomorphine can be decreased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Apomorphine.
Nicardipine Nicardipine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Apomorphine.
Ticlopidine Ticlopidine The metabolism of Apomorphine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Apomorphine.
Nisoldipine Nisoldipine The risk or severity of adverse effects can be increased when Apomorphine is combined with Nisoldipine.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Apomorphine is combined with Riluzole.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Amifostine.
Anastrozole Anastrozole The metabolism of Anastrozole can be decreased when combined with Apomorphine.
Indinavir Indinavir The metabolism of Apomorphine can be decreased when combined with Indinavir.
Ritonavir Ritonavir The metabolism of Apomorphine can be decreased when combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Apomorphine.
Clomipramine Clomipramine The risk or severity of adverse effects can be increased when Apomorphine is combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Apomorphine can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine Apomorphine may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril The risk or severity of adverse effects can be increased when Apomorphine is combined with Trandolapril.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Apomorphine.
Valsartan Valsartan The risk or severity of adverse effects can be increased when Apomorphine is combined with Valsartan.
Pramipexole Pramipexole Pramipexole may increase the sedative activities of Apomorphine.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Apomorphine is combined with Donepezil.
Nelfinavir Nelfinavir The metabolism of Apomorphine can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Azithromycin.
Loratadine Loratadine The metabolism of Apomorphine can be decreased when combined with Loratadine.
Carvedilol Carvedilol The risk or severity of adverse effects can be increased when Apomorphine is combined with Carvedilol.
Nilutamide Nilutamide The metabolism of Apomorphine can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Apomorphine can be decreased when combined with Flutamide.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Apomorphine is combined with Selegiline.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Apomorphine is combined with Sertraline.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Propafenone.
Raloxifene Raloxifene The metabolism of Apomorphine can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Apomorphine.
Tamsulosin Tamsulosin The risk or severity of adverse effects can be increased when Tamsulosin is combined with Apomorphine.
Ropinirole Ropinirole Ropinirole may increase the sedative activities of Apomorphine.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Apomorphine.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Apomorphine.
Paroxetine Paroxetine The risk or severity of adverse effects can be increased when Apomorphine is combined with Paroxetine.
Tolcapone Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Apomorphine.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Apomorphine is combined with Citalopram.
Efavirenz Efavirenz The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Efavirenz.
Sildenafil Sildenafil The metabolism of Apomorphine can be decreased when combined with Sildenafil.
Pioglitazone Pioglitazone The metabolism of Apomorphine can be decreased when combined with Pioglitazone.
Celecoxib Celecoxib The metabolism of Apomorphine can be decreased when combined with Celecoxib.
Rosiglitazone Rosiglitazone The metabolism of Apomorphine can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Apomorphine.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Apomorphine.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Apomorphine is combined with Levetiracetam.
Rabeprazole Rabeprazole The metabolism of Apomorphine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Apomorphine can be decreased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists